What does all this mean
Benefits were observed despite high baseline use of SGLT2i or MRA, without increasing the risk of SAEs
If youre worried, talk to your provider, who is best positioned to forecast how ECT might affect you specifically
Participants received either tirzepatide at 5mg, 10mg, or 15mg, or placebo, once weekly for 72 weeks
In general, the goal is to keep injections about one week apart to ensure steady effectiveness and minimise side effects
"A randomized, double-blind, placebo-controlled clinical trial using a low-frequency magnetic field in the treatment of musculoskeletal chronic pain." Pain Research & Management , 12(4), 249-258